Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human CEBPB Antibodies:
anti-Mouse (Murine) CEBPB Antibodies:
anti-Rat (Rattus) CEBPB Antibodies:
Go to our pre-filtered search.
Human Monoclonal CEBPB Primary Antibody for FACS, ELISA - ABIN969049
Cappello, Zwergal, Kanclerski, Haas, Kandemir, Huber, Page, Brand: C/EBPbeta enhances NF-kappaB-associated signalling by reducing the level of IkappaB-alpha. in Cellular signalling 2009
Human Polyclonal CEBPB Primary Antibody for ELISA, WB - ABIN4297625
Canettieri, Santaguida, Antonucci, Della Guardia, Franchi, Coni, Gulino, Centanni: CCAAT/enhancer-binding proteins are key regulators of human type two deiodinase expression in a placenta cell line. in Endocrinology 2012
Nr1d1/Rev-erbalpha (show NR1D1 Antibodies) has a direct role in circadian clock regulation of autophagy, which also involves Cebpb/(C/ebpbeta) indirectly in zebrafish
We found that quercetin reduces the promoter activity of apoB (show APOB Antibodies), driven by the enforced expression of C/EBPb.
Chromatin immunoprecipitation analysis revealed that C/EBPbeta2 binds to multiple sites at the 5' promoter/regulatory region, introns, and the 3' untranslated region of the IGF-II gene.
Palmitate can induce lipid accumulation in HepG2 cells by activating C/EBPbeta-mediated G0S2 (show G0S2 Antibodies) expression.
Anti-tumor effect of Rg3, which is mediated by inhibition of C/EBPbeta/NF-kappaB (show NFKB1 Antibodies) signaling.
C/EBPbeta upregulation promoted tumor cell invasion in an MMP3 (show MMP3 Antibodies)-dependent manner in vitro and was associated with metastatic status in colorectal cancer
findings support the hypothesis that maternal diabetes-induced ER stress increases CHOP (show DDIT3 Antibodies) expression which represses PGC-1alpha through suppressing the C/EBPbeta transcriptional activity, subsequently induces mitochondrial dysfunction and ultimately results in NTDs
Studies indicate that CCAAT enhancer binding protein beta (C/EBPB)-transcription factor CITED4 (CITED4 (show CITED4 Antibodies)) signaling is a pathway in cardioprotection mediating benefits of exercise in heart.
C/EBP beta LAP isoform expression was increased and LIP/TNFAIP3 (show TNFAIP3 Antibodies)/TNIP1 (show TNIP1 Antibodies) expression was decreased in systemic lupus erythematosus (SLE) patients. LAP expression was positively correlated with SLE disease activity; TNFAIP3 (show TNFAIP3 Antibodies) and TNIP1 (show TNIP1 Antibodies) expression was negatively correlated with SLE disease activity.
Overexpression of C/EBPbeta-1 increases transformation, upregulates expression of the cancer stem cell marker ALDH1A1 (show ALDH1A1 Antibodies), and leads to chemoresistance.
Elevated expression of CEBPB were associated with a decreased risk of hepatocellular carcinoma.
C/EBPbeta overexpression or knockdown did not change the levels of IL-1beta (show IL1B Antibodies)-induced SOCS1 (show SOCS1 Antibodies). SOCS1 (show SOCS1 Antibodies) regulated the levels of C/EBPbeta mRNA by ubiquitination of C/EBPbeta as well as transcriptional regulation in human chondrocytes.
C/EBPbeta suppresses miR-17-92 via two pathways - indirectly through induction of PU.1 expression, where it functions as an activator, and more efficiently, through direct interaction with the miR-17-92 promoter.
results support a stimulatory effect of Pb on adipogenesis which involves ERK (show EPHB2 Antibodies) activation and C/EBPbeta upregulation prior to PPARgamma (show PPARG Antibodies) and adipogenesis activation.
Purple sweet potato colour, a class of naturally occurring anthocyanins, exhibited beneficial effects on hepatic steatosis, which were associated with blocking Src (show SRC Antibodies) and C/EBPbeta activation.
Thus, this study identifies BCL11B (show BCL11B Antibodies) as a novel regulator of adipogenesis, which works, at least in part, by stimulating C/EBPbeta activity and suppressing the Wnt (show WNT2 Antibodies)/beta-catenin (show CTNNB1 Antibodies) signaling pathway.
Study shows that alpha melanocyte stimulating hormone (show POMC Antibodies) and forkhead box C2 protein promote fatty acid oxidation through C/EBPbeta negative transcription in mice adipose tissue.
The results indicated that miR-16 (show GDE1 Antibodies) was transactivated by C/EBP-beta resulting in aggravated Ischemia-reperfusion induced acute kidney injury and that urinary miR-16 (show GDE1 Antibodies) may serve as a potential biomarker for acute kidney injury.
These results suggest that C/EBPbeta is an endogenous initiator of neuropathic pain and could be a potential target for the prevention and treatment of this disorder.
We found that C/EBPbeta is phosphorylated by CK2 (show CSNK2A1 Antibodies) under AMPK (show PRKAA1 Antibodies) suppression and ER stress, which are important from the viewpoint of the worsening pathological condition of type 2 diabetes, such as decreased insulin (show INS Antibodies) secretion and apoptosis of pancreatic beta cells.
the extracts dramatically attenuated the levels of adipogenic transcriptional factors, including CCAAT enhancer-binding protein alpha (C/EBPa (show CEBPA Antibodies)), CCAAT enhancer-binding protein beta (C/EBPb), and gamma receptors by peroxisome proliferators (PPARg (show PPARG Antibodies)), during adipogenesis
Expression of the SENP2 (show SENP2 Antibodies) gene was suppressed by theobromine. In vivo knockdown studies showed that AR1 (show TCF20 Antibodies) knockdown in mice attenuated the anti-adipogenic effects of theobromine in younger mice. Theobromine suppresses adipocyte differentiation and induced C/EBPbeta degradation by increasing its sumoylation.
C/EBPbeta is a novel regulator of satellite cell self-renewal during muscle regeneration acting at least in part through Notch2 (show NOTCH2 Antibodies).
C/EBP-beta plays a vital role in regulating GPR120 (show O3FAR1 Antibodies) transcription.
The expression of porcine Prdx6 (show PRDX6 Antibodies) gene is up-regulated by C/EBPbeta and CREB (show CREB1 Antibodies).
Results show that expression changes of IGF1 (show IGF1 Antibodies) genes were associated with C/EBP (show CEBPA Antibodies) b expression during embryonic and postnatal development in porcine liver.
FoxO1 (show FOXO1 Antibodies) and C/EBPb regulate preadipocyte adipogenesis possibly through C/EBPb-> FoxO1 (show FOXO1 Antibodies)-> C/EBPb feedback regulatory loop and FoxO1 (show FOXO1 Antibodies)-C/EBPb protein complex.
the pig GPD1 (show GPD1 Antibodies) gene is regulated negatively by C/EBP beta in cultured kidney cells
GATA-4 (show GATA4 Antibodies) and C/EBPbeta are both required for FSH (show BRD2 Antibodies) +/- IGF-I (show IGF1 Antibodies) stimulation of the porcine steroidogenic acute regulatory protein (show STAR Antibodies) gene promoter in homologous granulosa cell cultures.
The differential expression of specific CEBPA (show CEBPA Antibodies)/B isoforms observed in maturing follicles and CL may contribute to changes in follicular cell differentiation and increasing steroidogenic capacity.
SREBP1a activated while C/EBP (show CEBPA Antibodies) factors downregulated the activity of the SCD1 (show SCD Antibodies) promoter.
These results indicate that the C/EBPbeta gene plays an important regulatory role in regulation of the cell cycle regulators and spermatogenesis-related (show SYCE2 Antibodies) genes expression and function of bovine SCs (show TWIST1 Antibodies).
Suppression of CPT1B (show CPT1B Antibodies) and induction of SCD (show SCD Antibodies) and CEBPB by supplemental arginine promotes increased adiposity in Angus steers.
Co-culture of adipocytes and myoblasts elicited an increase in C/EBPbeta and PPAR-gamma (show PPARG Antibodies) gene expression in differentiated myoblasts and an increase in GPR43 (show FFAR2 Antibodies) gene expression in adipocytes.
Interaction of C/EBP-beta and NF-Y factors constrains activity levels of the nutritionally controlled promoter IA expressing the acetyl-CoA carboxylase-alpha (show ACACA Antibodies) gene in cattle.
The role of NF-kappaB (show NFKB1 Antibodies) and C/EBP (show CEBPA Antibodies) factors in regulating basal and pathogen-induced expression of both genes from cattle, is investigated.
The 3' terminal end of the first intron of porcine SPP1 (show SPP1 Antibodies) harbors a C/EBPbeta binding site and this binding site is negatively affected by the mutant G allele.
2-chloroethyl ethyl sulfide (show SQRDL Antibodies) exposure caused a 2.3-fold increase in the activation of C/EBP (show CEBPA Antibodies) accompanied with a 45% and 121% increase in the protein level of C/EBP beta and ICAM-1 (show ICAM1 Antibodies), respectively, and this effect was counteracted by the antioxidant liposome.
The protein encoded by this intronless gene is a bZIP transcription factor which can bind as a homodimer to certain DNA regulatory regions. It can also form heterodimers with the related proteins CEBP-alpha, CEBP-delta, and CEBP-gamma. The encoded protein is important in the regulation of genes involved in immune and inflammatory responses and has been shown to bind to the IL-1 response element in the IL-6 gene, as well as to regulatory regions of several acute-phase and cytokine genes. In addition, the encoded protein can bind the promoter and upstream element and stimulate the expression of the collagen type I gene.
CCAAT/enhancer binding protein (C/EBP), beta
, CCAAT/enhancer-binding beta protein b
, CCAAT/enhancer-binding protein beta
, CCAAT/enhancer binding protein beta
, interleukin 6-dependent DNA-binding protein
, liver-enriched transcriptional activator protein
, nuclear factor NF-IL6
, nuclear factor of interleukin 6
, transcription factor 5
, C/EBP BETA
, interleukin-6-dependent-binding protein
, liver-enriched transcriptional activator
, nuclear protein Il6
, C/EBP beta
, c/EBP-related protein 2
, liver activating protein (LAP)
, nuclear factor-IL6
, silencer factor B
, c/EBP beta
, CCAAT box/enhancer binding protein beta
, CCR protein
, transcription factor NF-M